Skip to main content

Main menu

  • About
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Strategic Plan
    • News and Stories
    • Careers
  • Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health
      • Healthy Aging and Mobility
      • Heart Health
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
      • Other Research Focus Areas
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Dilawri Cardiovascular Institute
      • Djavad Mowafaghian Centre for Brain Health
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
    • Research Cores
      • Clinical Trials Platform
      • VCH-VCHRI AI Hub
      • Indigenous Health Research Unit
    • Researcher Directory
    • Events and Workshops
    • Participate in Research
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
    • Research Development
      • Awards and Funding
      • Research Facilitation
      • Grant Management
      • Learning and Development
    • Contracts and Compliance
      • Contract Facilitation at VCHRI
      • Operational Approval
      • Research Privacy
      • Clinical Trials Administration
    • Research Support
      • Communications and Media Relations
      • Financial Policies and Procedures
      • VCH-VCHRI AI Hub
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Clinical Trials
    • Clinical Trials Platform
      • Phase 1 Clinical Trials Research Unit
      • Hematology Research Unit
      • Clinical Research Unit
    • Find a Study
    • Researcher Directory
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Research
  3. Participate in Research
  4. The adverse drug event that almost took my life

The adverse drug event that almost took my life

Participate in Research Oct 18, 2024 3 minutes

"I say yes to participate in research because it can prevent something negative from happening and help other people."

– Glen Medcalf, Vancouver

Just before Thanksgiving in 2023, Glen Medcalf’s wife, Lorrie, woke up to him thrashing in bed. “She told me that we needed to go to the hospital,” recalls Medcalf. “That’s the last thing that I remember.”

Glen Medcalf and his wife, Lorrie, in the hospital.

Medcalf was taken by ambulance to the emergency department. His vital signs were in the extremes and his throat was swelling up. Doctors, including attending emergency physician Dr. Corinne Hohl, a Vancouver Coastal Health Research Institute researcher, were fighting to save Medcalf’s life.  

“At one point, he stopped breathing,” remembers Hohl. “His pH was 6.67, which was the lowest that I had ever seen in a patient.” A healthy pH level of blood and other fluids is between 7.35 and 7.45, with anything above or below requiring immediate emergency medical attention.

“Given what we were seeing, I suspected that he was likely experiencing an adverse drug event (ADE) caused by one of the medications he was taking,” says Hohl. 

After waking up from a coma, Medcalf recalls noticing the feeding tube in his throat and feeling weak and disoriented. “Lorrie was very worried about me,” he recalls. “A family friend told me that she had been a pile of jelly on the floor when I was in the emergency department.”

“Over two million Canadians visit an emergency department every year due to adverse drug events.”

An ADE is an unintended and harmful occurrence associated with one or more medications. Repeat ADEs are when a medication that previously caused harm is mistakenly re-prescribed. This most commonly happens when a care team is not aware about a prior ADE because they are not connected to information about a patient’s ADE history. 

Medcalf, who also lives with type 2 diabetes and high blood pressure, was managing his conditions with several medications, including Metformin, a common treatment for diabetes. However, in Medcalf, the medication caused a life-threatening adverse event called Metformin-induced lactic acidosis.

“Adverse drug events contribute to or cause one out of every nine patient admissions to the emergency department. One out of every three adverse drug events presenting to the emergency department is the result of a patient being re-prescribed the same medication.”

Hohl and her team created ActionADE to reduce unintentional re-exposures to previously harmful medications. The electronic platform can communicate information to community and hospital pharmacies across health sectors using the provincial PharmaNet network already in place at these facilities. Currently part of a randomized controlled trial, the goal of ActionADE is to increase patient safety, states Hohl.

Dr. Corinne Hohl practises emergency medicine at Vancouver General Hospital. She is a scientist at the Centre for Clinical Epidemiology and Evaluation, and professor and head of the Department of Emergency Medicine at the University of British Columbia.

“We do not want health providers to operate in silos, tracking ADEs only in their offices or at individual hospitals,” states Hohl. “We need a centralized database that offers an integrated ADE warning system that can prevent health providers from unknowingly re-exposing patients when re-exposure is not clinically indicated. ActionADE offers this solution.”

Prior to his 2023 hospitalization, Medcalf was admitted to hospital once in 2020 and again in 2021 for an ADE to the same culprit medication. Although less severe than what he would later experience in 2023, Medcalf’s broader care team did not receive or see the information about his ADE or its cause, resulting in him being re-prescribed the medication despite its harmful effects.

Watch Glen Medcalf share his ADE experience in this video:

Now in good spirits and health, Medcalf sits on the ActionADE research team as a patient partner. By sharing his story, Medcalf hopes to facilitate changes to the medical system that can help prevent future ADEs and patient harm. 

“Everyone in the ActionADE group has something to contribute,” says Medcalf. “As a patient partner, I am there to share my experience and help the research team arrive at solutions.” 

Learn more about Dr. Corinne Hohl’s research and ActionADE here.
 

This is one patient's story of participating in a research study. Your experience may differ. Learn about clinical trials before participating.

Researchers

Corinne Hohl

Related Articles

David Walker’s life is even sweeter with Parkinson’s lifestyle skills

Bringing cardiac recovery home

Wearable alert system to prevent Parkinson’s medication ‘wearing off’ symptoms

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Instagram
  • Email

Related Research Centres/Programs

Emergency Medicine Research Program

Centre for Clinical Epidemiology and Evaluation

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Stories

Ask an expert: How can I strike a healthier balance with my daily habits?

Sep 10, 2026 exercise, mobility
Type
Stories

Moving endometrial cancer prevention upstream

Sep 8, 2026 women, cancer, uterine
Type
Stories

Improving respiratory protection for wildland firefighters

Sep 3, 2026 lung, environment, safety
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • Instagram
  • Bluesky
  • YouTube

© 2026 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy